(IMVT) - Analyst Ratings

(IMVT) – Analyst Ratings

Mar 27, 2024 04:04 PM Oppenheimer Starts Immunovant (IMVT) at Outperform, 'expect the execution to unlock considerable value'
Mar 21, 2024 09:32 AM Guggenheim reiterates Buy rating on Tourmaline Bio (TRML), "news is likely to increase investors' perceived risk"
Mar 13, 2024 05:29 AM
Feb 20, 2024 04:20 AM
Feb 15, 2024 03:43 PM
Feb 15, 2024 04:48 AM
Dec 20, 2023 07:47 AM
Dec 11, 2023 04:08 PM
Oct 13, 2023 04:37 AM
Oct 9, 2023 08:54 AM
Sep 26, 2023 10:28 AM
Sep 26, 2023 06:51 AM
Sep 26, 2023 06:47 AM
Sep 26, 2023 06:46 AM
Aug 7, 2023 04:24 AM
May 1, 2023 06:07 AM
Apr 25, 2023 07:43 AM
Mar 31, 2023 03:45 AM
Mar 29, 2023 04:07 PM
Feb 15, 2023 05:52 AM
Feb 13, 2023 06:13 AM
Jan 3, 2023 03:59 AM
Sep 26, 2022 04:41 AM
Mar 23, 2022 10:12 AM
Dec 30, 2021 11:44 AM
Dec 30, 2021 11:15 AM
Dec 7, 2021 04:43 PM
Aug 3, 2021 09:08 AM
Aug 2, 2021 12:47 PM
Jun 1, 2021 03:31 PM
Jun 1, 2021 01:22 PM
Jun 1, 2021 11:45 AM
Jun 1, 2021 10:27 AM
Feb 2, 2021 01:33 PM
Feb 2, 2021 10:36 AM
Feb 2, 2021 09:36 AM
Nov 13, 2020 07:37 AM
Nov 12, 2020 04:47 PM
Oct 27, 2020 05:02 PM
Oct 12, 2020 06:18 AM
Oct 7, 2020 04:27 PM
Oct 2, 2020 04:16 AM
Aug 25, 2020 01:54 PM
Aug 25, 2020 11:01 AM
Aug 24, 2020 04:28 PM
Aug 19, 2020 08:38 AM
Aug 19, 2020 08:08 AM
Aug 13, 2020 08:31 AM
Jul 29, 2020 06:10 AM
May 29, 2020 08:15 AM